Holen Sie sich die Stockscreener-App
0.851
1.77%
0.0148
Handel nachbörslich:
.86
0.009
+1.06%
Schlusskurs vom Vortag:
$0.8362
Offen:
$0.8358
24-Stunden-Volumen:
63,557
Relative Volume:
0.35
Marktkapitalisierung:
$8.04M
Einnahmen:
$34.07M
Nettoeinkommen (Verlust:
$-20.13M
KGV:
-0.0659
EPS:
-12.92
Netto-Cashflow:
$-24.90M
1W Leistung:
+0.35%
1M Leistung:
+34.65%
6M Leistung:
-22.64%
1J Leistung:
-26.00%
1-Tages-Spanne:
$0.7933
$0.8652
1-Wochen-Bereich:
$0.7933
$0.8999
52-Wochen-Spanne:
$0.536
$2.22
Biofrontera Inc Stock (BFRI) Company Profile
Firmenname
Biofrontera Inc
Sektor
Telefon
781-245-1325
Adresse
120 PRESIDENTIAL WAY,, WOBURN
Vergleichen Sie BFRI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BFRI
Biofrontera Inc
|
0.851 | 8.01M | 34.07M | -20.13M | -24.90M | -12.92 |
|
ZTS
Zoetis Inc
|
150.03 | 70.70B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.74 | 46.87B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.59 | 45.41B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.31 | 18.96B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
297.33 | 13.54B | 2.99B | 1.21B | 1.13B | 25.06 |
Biofrontera Inc Aktie (BFRI) Neueste Nachrichten
Biofrontera's Stock Sale: Weighing Dilution Risks Against Biotech Sector Opportunities - AInvest
What makes Biofrontera Inc. stock price move sharplyFree Stock Selection - Newser
How Biofrontera Inc. stock performs during market volatilityTop Growth Low Risk Stocks - Newser
How Biofrontera Inc. Equity Warrant stock performs during market volatilityFree Discussion Group - Newser
What makes Biofrontera Inc. Equity Warrant stock price move sharplyBig Return Stock Tips - Newser
Why Biofrontera Inc. Equity Warrant stock attracts strong analyst attentionVerified Return Tips - Newser
Why Biofrontera Inc. stock attracts strong analyst attentionHigh Return Setup Scanner - Newser
BFRI’s Stock Dilemma: Biofrontera Inc’s Market Performance and Outlook - investchronicle.com
Biofrontera restructures relationship with Biofrontera AG, backed by $11M investment - MSN
Q3 Earnings Forecast for Biofrontera Issued By Roth Capital - Defense World
Biofrontera Inc. restructures relationship with Biofrontera AG - TipRanks
Biofrontera stock rises after restructuring agreement with Biofrontera AG - Investing.com
Biofrontera stock rises after restructuring agreement with Biofrontera AG By Investing.com - Investing.com UK
Biofrontera Inc. announced that it expects to receive $11 million in funding from Aigh Capital Management, LLC, Rosalind Advisors, Inc. - MarketScreener
Biofrontera Inc. Announces Major Restructuring of Relationship With Biofrontera AG Backed By $11 Million Investment - GlobeNewswire
Biofrontera Restructures U.S. Rights with $11M Investment - TipRanks
PTA-Adhoc: Biofrontera AG: EXTENSION OF BIOFRONTERA INC. PAYMENT DEFERRALUPDATE - TradingView
Biofrontera AG Extends Payment Deferral Amid Strategic Negotiations - TipRanks
Biofrontera Holds Annual Stockholders Meeting, Key Decisions Made - TipRanks
Biofrontera AG Extends Payment Deferral Amid Ongoing Negotiations - TipRanks
Short Interest in Biofrontera Inc. (NASDAQ:BFRI) Increases By 74.8% - Defense World
Biofrontera Inc. (BFRI) Engages in Strategic Talks with Biofront - GuruFocus
National Crime Prevention Council Urges McDonald's to End Snapchat Partnership Over Child Safety Concerns - The Manila Times
Biofrontera Inc. Confirms Talks on Merger, Licensing Changes with Biofrontera AG - MarketScreener
Biofrontera Inc. Negotiates Cooperation Changes with Biofrontera AG - TipRanks
Biofrontera in talks with AG parent for possible merger or deal terms - Investing.com India
Biofrontera Inc. Confirms Negotiations for Potential Combination with Biofrontera AG - Nasdaq
Biofrontera in talks with AG parent for possible merger or deal terms By Investing.com - Investing.com South Africa
BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG - GlobeNewswire
Biofrontera Inc Explores Merger with Parent Company, Major US License Agreement Changes on Table - Stock Titan
Biofrontera AG Explores Strategic Changes with Biofrontera Inc. - TipRanks
Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update - mx.advfn.com
Actinic Keratosis Treatment Market SWOT Analysis by Leading Expert: Almirall, Biofrontera, Nestle - newstrail.com
Biofrontera secures patent for Ameluz formulation until 2043 By Investing.com - Investing.com South Africa
biofrontera inc. revises proxy statement disclosure By Investing.com - Investing.com South Africa
biofrontera inc. revises proxy statement disclosure - Investing.com
Biofrontera Updates Proxy Statement for 2025 Meeting - TipRanks
Biofrontera Glycol-Free Skin Gel Added to FDA 'Orange Book;' Shares Rise - marketscreener.com
Biofrontera Inc. (BFRI) Propylene Glycol-Free Patent Gains FDA R - GuruFocus
Biofrontera Inc. (BFRI) Propylene Glycol-Free Patent Gains FDA Recognition | BFRI Stock News - GuruFocus
Biofrontera secures patent for Ameluz formulation until 2043 - Investing.com
Biofrontera announces inclusion of patent in FDA Orange Book - TipRanks
Biofrontera Inc. Announces Patent for Propylene Glycol-Free - GlobeNewswire
Finanzdaten der Biofrontera Inc-Aktie (BFRI)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
3.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):